Endocrine therapy with selective estrogen receptor modulators (SERM), such as tamoxifen and AI, plays an important role in the treatment of breast cancer overexpressing hormone receptors, such as ER and PR receptors [52]. This evidence concerns the gene ESR1 and breast cancer.